학술논문

1508MO Rationalizing the use of off-label drugs (OLD) within a special medication (ME) program for cancer patients (pt): The Catalan Institute of Oncology (ICO) prognostic score (ICO MEscore)
Document Type
Abstract
Source
In Annals of Oncology September 2021 32 Supplement 5:S1105-S1105
Subject
Language
ISSN
0923-7534